Frontlight ResearchEarly access
What researchers published on Pompe disease
1,192 papers, newest first.
Showing 20 of 147
ReviewInfusion-associated reactions during enzyme replacement therapy in late-onset Pompe disease: a systematic review and proposed management algorithm.Molecular genetics and metabolism
Systematic reviewThe Genetic Landscape of Pompe Disease in the Middle East, North Africa, and Turkey (MENAT Region): A Systematic Review of GAA Variants and Genotype-Phenotype Correlation.International journal of molecular sciences
In plain wordsRead moreRead the paper on PubMedReviewInfantile-Onset Pompe Disease: Current Therapeutic Landscape, Clinical Challenges, and Future Horizons.Cureus
ReviewGenome Editing for Glycogen Storage Diseases.Journal of inherited metabolic disease
ReviewDefining the therapeutic corridor of stability in enzyme replacement therapy for Pompe disease: a position statement.Orphanet journal of rare diseases
Systematic reviewCentral nervous system histopathological findings in classic infantile Pompe disease: a systematic review with clinical relevance.Journal of neurology
In plain wordsRead moreRead the paper on PubMedReviewA Comprehensive Update on Pompe Disease: From Existing Therapies to Emerging Curative Strategies.International journal of molecular sciences
ReviewPompe Disease: Pathogenesis, Molecular Mechanisms, Neurological Aspects, Diagnostics and Modern Therapeutic Approaches.International journal of molecular sciences
Systematic reviewCardiac magnetic resonance in Pompe disease: a systematic literature review.La Radiologia medica
In plain wordsRead moreRead the paper on PubMedReviewEpigenetic modulation of the gut-muscle axis in pompe disease: Microbiota fingerprints to cellular and molecular pathomechanisms.Molecular metabolism
ReviewGenetic Mutations Underlying Growth Impairment and Cardiomyopathies in Children: Molecular Mechanisms, Clinical Implications and Targeted Therapies.Genes
ReviewComprehensive review of recent advances in Pompe disease: pathogenesis, management, and future directions.Frontiers in neurology
ReviewMiglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease.Therapeutic advances in rare disease
Meta-analysisComparing the efficacy of cipaglucosidase alfa plus miglustat with alglucosidase alfa for late-onset Pompe disease: an expanded network meta-analysis utilizing patient-level and aggregate data.Journal of comparative effectiveness research
Systematic reviewLessons from late-onset Pompe disease identified by Newborn screening: A systematic review.Molecular genetics and metabolism
In plain wordsRead moreRead the paper on PubMedSystematic reviewEnzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis.Health technology assessment (Winchester, England)
In plain wordsRead moreRead the paper on PubMedReviewA roadmap for a patient-centred approach to Pompe disease management.Journal of neurology
ReviewMeasuring What Matters to Patients with Pompe Disease: A Review of Clinical Outcome Assessments for Capturing Treatment Benefits of Innovative Novel Therapies.Advances in therapy
Systematic reviewInsights into immunogenicity and therapeutic strategies to mitigate the immune response in infantile-onset Pompe disease: a comprehensive systematic literature review.Frontiers in immunology
In plain wordsRead moreRead the paper on PubMedReviewA comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experience.Current opinion in immunology